中国全科医学 ›› 2024, Vol. 27 ›› Issue (16): 2033-2038.DOI: 10.12114/j.issn.1007-9572.2023.0084

所属专题: 心血管最新文章合集

• 综述与专论 • 上一篇    下一篇

非酒精性脂肪性肝病、代谢相关脂肪性肝病与心血管疾病关联的国内外研究进展

倪雪桐1, 王若羲1, 张晶2, 杨兴华1,*()   

  1. 1.100069 北京市,首都医科大学公共卫生学院 临床流行病学北京市重点实验室
    2.100069 北京市,首都医科大学附属北京佑安医院肝病中心三科
  • 收稿日期:2023-08-07 修回日期:2023-10-24 出版日期:2024-06-05 发布日期:2024-04-08
  • 通讯作者: 杨兴华

  • 作者贡献:

    倪雪桐负责论文整体写作构思、制定检索策略、收集与整理文献、撰写论文和论文修订;王若羲负责文献搜集与整理;张晶负责文章的修订与质量控制;杨兴华负责论文的修订、文章的质量控制及审校。

  • 基金资助:
    北京市自然科学基金资助项目(7202010)

Research Progress in the Correlation of Non-alcoholic Fatty Liver Disease and Metabolic-associated Fatty Liver Disease with Cardiovascular Diseases in China and Abroad

NI Xuetong1, WANG Ruoxi1, ZHANG Jing2, YANG Xinghua1,*()   

  1. 1. School of Public Health, Capital Medical University/Beijing Key Laboratory of Clinical Epidemiology, Beijing 100069, China
    2. Department Ⅲ, Liver Disease Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China
  • Received:2023-08-07 Revised:2023-10-24 Published:2024-06-05 Online:2024-04-08
  • Contact: YANG Xinghua

摘要: 非酒精性脂肪性肝病(NAFLD)是目前全球最常见的慢性肝病,近年来大量研究证明其与代谢障碍密切相关,专家小组提出将其更名为代谢相关脂肪性肝病(MAFLD)。NAFLD/MAFLD不仅可能导致肝脏相关疾病的发病率和死亡率增加,也与心血管疾病的发病和死亡相关。本文对NAFLD/MAFLD的诊断标准进行比较,并总结了NAFLD/MAFLD与心血管疾病的关联性研究进展。结果表明,NAFLD/MAFLD与心血管疾病发病率增加均存在显著相关性,是心血管疾病的影响因素,且MAFLD患者心血管疾病发病风险高于NAFLD患者。本文为临床医生提供了对NAFLD/MAFLD患者进行心血管疾病风险评估和管理的依据,提示临床医生在处理NAFLD/MAFLD患者时,除了关注肝脏疾病的治疗外,还应重视患心血管疾病的风险。

关键词: 非酒精性脂肪性肝病, 代谢相关脂肪性肝病, 心血管疾病, 关联性研究, 综述

Abstract:

Non-alcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease worldwide, its close correlation with metabolic disorders has been demonstrated in numerous studies in recent years and an expert panel has proposed renaming it metabolic-associated fatty liver disease (MAFLD). NAFLD/MAFLD may not only increase the incidence and mortality of liver-related diseases but also relate to the incidence and mortality of cardiovascular diseases. This article compares the diagnostic criteria of NAFLD/MAFLD and reviews the research progress in the correlation of non-alcoholic fatty liver disease and metabolic-associated fatty liver disease with cardiovascular diseases. The results show that both NAFLD/MAFLD are significantly associated with the increased incidence of cardiovascular diseases and independent risk factors for cardiovascular diseases. Furthermore, MAFLD patients have a higher risk of developing cardiovascular diseases than NAFLD patients. This article provides clinical physicians with the basis for cardiovascular risk assessment and management in NAFLD/MAFLD patients, emphasizing that in addition to the treatment of liver disease, clinical physicians should also focus on the risk of cardiovascular disease in NAFLD/MAFLD patients.

Key words: Non-alcoholic fatty liver disease, Metabolic associated fatty liver disease, Cardiovascular diseases, Association study, Review

中图分类号: